MDM2 and Miyoshi myopathy: For the first time, we demonstrate that MDM2 and c-Myc reciprocally regulate each other via a positive feedback loop and MX69 is an effective anti-myeloma agent that re-sensitizes drug-resistant MM cells to conventional MM therapies.